Ignite Creation Date:
2024-05-05 @ 11:29 AM
Last Modification Date:
2024-10-26 @ 9:08 AM
Study NCT ID:
NCT00057915
Status:
COMPLETED
Last Update Posted:
2014-09-08
First Post:
2003-04-07
Brief Title:
Vaccine Therapy in Treating Patients With Refractory Stage IV Cancer
Sponsor:
Duke University
Organization:
Duke University
Organization Data
Organization:
Duke University
Class:
OTHER
Study ID:
4180
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Duke University
Lead Sponsor Class:
OTHER
Responsible Party:
Michael Morse MD
Responsible Party Title:
Principal Investigator
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Duke University
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| National Cancer Institute NCI | NIH |